U.S. Market for Tamper Evident Caps for IV & Oral Syringes
In 2012, it expected there were be over 40 million tamper evident caps sold in the U.S., an increase of over the previous year. This market is being driven by the growth in the plastic and glass prefilled syringes segment and by the increased penetration of tamper evident devices for these prefilled syringes.
For plastic prefilled syringes, the majority of them are filled with either saline or heparin, and because these solution are not caustic or controlled substances, it is unlikely that they will use any type of tamper evident device because it is not cost effective. However, the remaining 1% of the plastic prefilled syringes that contain vaccines, cough medicine and pain relief medication may use a tamper evident device, and tamper evident caps have the potential to increase their penetration rate in that subsegment. Glass prefilled syringes are almost exclusively filled with drugs instead of heparin or flushing solutions, and while the penetration rate for tamper evident caps for glass prefilled syringes is relatively low, there is great potential for all types of tamper evident devices to increase their use with glass prefilled syringes.
Scope: This report pertains to a forecast period of 10 years (2008 – 2018) for the U.S.
Report Contents:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
For plastic prefilled syringes, the majority of them are filled with either saline or heparin, and because these solution are not caustic or controlled substances, it is unlikely that they will use any type of tamper evident device because it is not cost effective. However, the remaining 1% of the plastic prefilled syringes that contain vaccines, cough medicine and pain relief medication may use a tamper evident device, and tamper evident caps have the potential to increase their penetration rate in that subsegment. Glass prefilled syringes are almost exclusively filled with drugs instead of heparin or flushing solutions, and while the penetration rate for tamper evident caps for glass prefilled syringes is relatively low, there is great potential for all types of tamper evident devices to increase their use with glass prefilled syringes.
Scope: This report pertains to a forecast period of 10 years (2008 – 2018) for the U.S.
Report Contents:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment
- Trend Analysis by Segment
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
- Prefilled Syringes and Tamper Evident Devices
- Prefilled Syringe Administration Types
- Sub-Segments Included:
- Oral Tamper Evident Cap Market
- Sterile Tamper Evident Cap Market
- Plastic Prefilled Syringes
- Glass Prefilled Syringes
- Companies Included:
- PharMEDium/B. Braun
- International Medical Industries
- Ameridose
- Health Care Logistics
- Baxa Corporation/Baxter International
- Medi-Dose/EPS/Vu-Pak
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
U.S. TAMPER EVIDENT CAP MARKET
2.1 INTRODUCTION
2.1.1 Prefilled Syringes and Tamper Evident Devices
2.1.2 Prefilled Syringe Administration Types
2.2 MARKET ANALYSIS & FORECAST
2.2.1 Total Tamper Evident Cap Market
2.2.2 Sterile Tamper Evident Cap Market
2.2.3 Oral Tamper Evident Cap Market
2.3 DRIVERS AND LIMITERS
2.3.1 Market Drivers
2.3.2 Market Limiters
2.4 COMPETITIVE ANALYSIS
2.4.1 Emerging Competitors and Markets
APPENDIX
3.1 PREFILLED SYRINGES
3.1.1 Plastic Prefilled Syringes
3.1.2 Glass Prefilled Syringes
ABBREVIATIONS
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
U.S. TAMPER EVIDENT CAP MARKET
2.1 INTRODUCTION
2.1.1 Prefilled Syringes and Tamper Evident Devices
2.1.2 Prefilled Syringe Administration Types
2.2 MARKET ANALYSIS & FORECAST
2.2.1 Total Tamper Evident Cap Market
2.2.2 Sterile Tamper Evident Cap Market
2.2.3 Oral Tamper Evident Cap Market
2.3 DRIVERS AND LIMITERS
2.3.1 Market Drivers
2.3.2 Market Limiters
2.4 COMPETITIVE ANALYSIS
2.4.1 Emerging Competitors and Markets
APPENDIX
3.1 PREFILLED SYRINGES
3.1.1 Plastic Prefilled Syringes
3.1.2 Glass Prefilled Syringes
ABBREVIATIONS
